Stilla Technologies Prism Six-Color Digital PCR System
Stilla Technologies has launched the Prism digital PCR system featuring six-color detection capability. The system builds upon the company's current three-color Naica digital PCR system and has been validated for use with a six-color lung cancer panel for EGFR mutation quantification in liquid biopsy-based monitoring in breast and rectal cancer. The company first described the six-color workflow for non-small cell lung cancer mutations in a proof-of-concept study published last year, and replicated the approach to validate the breast and rectal cancer panels.
The system has also been validated for use with a panel for detecting and quantifying genetically modified organisms in the food supply, the company said. The new system can provide results in under three hours, uses the same workflow as the Naica system, and is compatible with current Stilla consumables.